Literature DB >> 26944380

Imipenem/cilastatin-induced acute eosinophilic pneumonia.

Kap Sum Foong1, Ashley Lee2, Marijeta Pekez2, Wei Bin3.   

Abstract

Drugs, toxins, and infections are known to cause acute eosinophilic pneumonia. Daptomycin and minocycline are the commonly reported antibiotics associated with acute eosinophilic pneumonia. In this study, we present a case of imipenem/cilastatin-induced acute eosinophilic pneumonia. The patient presented with fever, acute hypoxic respiratory distress, and diffuse ground-glass opacities on the chest CT a day after the initiation of imipenem/cilastatin. Patient also developed peripheral eosinophilia. A reinstitution of imipenem/cilastatin resulted in recurrence of the signs and symptoms. A bronchoscopy with bronchoalveolar lavage showed 780 nucleated cells/mm(3) with 15% eosinophil. The patient's clinical condition improved significantly after the discontinuation of imipenem/cilastatin therapy and the treatment with corticosteroid. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944380      PMCID: PMC4785424          DOI: 10.1136/bcr-2016-214804

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.

Authors:  Becky A Miller; Alice Gray; Thomas W Leblanc; Daniel J Sexton; Andrew R Martin; Thomas G Slama
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

Review 2.  Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia.

Authors:  Joshua Solomon; Marvin Schwarz
Journal:  Semin Respir Crit Care Med       Date:  2006-04       Impact factor: 3.119

Review 3.  Acute eosinophilic pneumonia.

Authors:  James Allen
Journal:  Semin Respir Crit Care Med       Date:  2006-04       Impact factor: 3.119

4.  Idiopathic acute eosinophilic pneumonia: a study of 22 patients.

Authors:  François Philit; Bénédicte Etienne-Mastroïanni; Antoine Parrot; Claude Guérin; Dominique Robert; Jean-François Cordier
Journal:  Am J Respir Crit Care Med       Date:  2002-11-01       Impact factor: 21.405

Review 5.  Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports.

Authors:  Jason Phillips; Anthony P Cardile; Thomas F Patterson; James S Lewis
Journal:  Scand J Infect Dis       Date:  2013-07-05

Review 6.  Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature.

Authors:  A L Pope-Harman; W B Davis; E D Allen; A J Christoforidis; J N Allen
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

7.  Increased vascular endothelial growth factor in acute eosinophilic pneumonia.

Authors:  Y Nishigaki; S Fujiuchi; Y Yamazaki; H Matsumoto; A Takeda; Y Fujita; K Okamoto; T Fujikane; T Shimizu; K Kikuchi
Journal:  Eur Respir J       Date:  2003-05       Impact factor: 16.671

8.  Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure.

Authors:  J N Allen; E R Pacht; J E Gadek; W B Davis
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

Review 9.  Drug-induced eosinophilic lung disease.

Authors:  James N Allen
Journal:  Clin Chest Med       Date:  2004-03       Impact factor: 2.878

10.  Minocycline-induced acute eosinophilic pneumonia: A case report and review of the literature.

Authors:  Sharon W Hung
Journal:  Respir Med Case Rep       Date:  2015-05-30
  10 in total
  1 in total

1.  Meropenem: A possible new culprit in eosinophilic lung diseases.

Authors:  Nathalie Abi Hatem; Sabrina Campbell; Edmundo Rubio; Anthony Lukas Loschner
Journal:  Lung India       Date:  2017 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.